Experimental study of the inhibition of minichromosomal maintenance 7 expression of different chemotherapeutic drugs on cervical cancer xenografts

Luo Yanyan,Lin Zhongqiu
DOI: https://doi.org/10.3969/j.issn.1004-7379.2006.09.002
2006-01-01
Abstract:Objective:To study the the inhibition of expression level of minichromosomal maintenance 7(MCM7) of cervical cancer xenografts treated with platinum and fluoroprimidine drugs.Methods:The HeLa cells were subcutaneous injected into the female nude mice of 4~6 weeks of age.The mice were divided into 8 groups according to the drugs,namely,A:control group,B1:cisplatin,B2:carboplatin,B3:5-FU,B4:capecitabine,B5:cisplatin+5-FU,B6:cisplatin+capecitabine,B7:carboplatin+5-FU.MCM7 expression was evaluated by RT-PCR,and was compared to the parameters,such as the volume and weight of the tumors and the inhibition ration.Results:The MCM7 expression of group B1、B2、B5、B6、B7 was significantly less than that of control group(P<0.05).On the other hand,the MCM7 expression of group B7 was also significantly less than that of B4(P<0.05).However,there was no interaction effect between B7 and B4 by multifactorial analysis.Conclusion:The drug that had stronger inhibition effect might be had lower expression of MCM7,MCM7 may be a new indicator to evaluate the curative effect of chemotherapy on cervical cancer.
What problem does this paper attempt to address?